Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Autoimmune Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering.
Autoimmune Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the autoimmune deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of 943 autoimmune deals from 2016 to 2025.
The report includes coverage of the following autoimmune diseases:
Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Glomerulonephritis, Endometriosis, Immune thrombocytopenic purpura, Neutropenia, Graft versus host disease, Scleroderma, Systemic lupus erythematosus, Addison's disease, Diabetes Type 1, Ankylosing spondylitis, Juvenile arthritis, Psoriatic arthritis, Rheumatoid arthritis, Uveitis, Narcolepsy, Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Sarcoidosis, Meniere's disease, and other autoimmune disorders.
The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of collaboration and licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters provide a valuable orientation to autoimmune dealmaking, beginning with an introduction in Chapter 1. Chapter 2 delves into trends within autoimmune dealmaking, offering a comprehensive analysis. The subsequent chapters provide detailed insights, covering the financial aspects of deals (Chapter 3), reviewing top active companies (Chapter 4), examining notable signed deals (Chapter 5), and presenting a directory organized by therapeutic target (Chapter 6).
The report also includes numerous table and figures that illustrate the trends and activities in autoimmune deal making since 2016.
In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Autoimmune Collaboration and Licensing Deals provides the reader with the following key benefits:
- Understand deal trends since 2016
- Browse autoimmune collaboration and licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report Scope
Autoimmune Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of autoimmune trends and structure of deals entered into by leading biopharma companies worldwide.
Autoimmune Collaboration and Licensing Deals includes:
- Trends in autoimmune dealmaking in the biopharma industry
- Overview of collaboration and licensing deal structure
- Directory of autoimmune deal records covering pharmaceutical and biotechnology
- The leading autoimmune deals by value
- Most active autoimmune licensing dealmakers
In Autoimmune Collaboration and Licensing Deals, the available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
Autoimmune Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in autoimmune dealmaking
2.1. Introduction
2.2. Autoimmune deals over the years
2.3. Autoimmune deals by deal type
2.4. Autoimmune deals by industry sector
2.5. Autoimmune deals by stage of development
2.6. Autoimmune deals by technology type
Chapter 3 - Financial deal terms for autoimmune deals
3.1. Introduction
3.2. Disclosed financials terms for autoimmune deals
3.3. Autoimmune deal headline values
3.4. Autoimmune deal upfront payments
3.5. Autoimmune deal milestone payments
3.6. Autoimmune deal royalty rates
Chapter 4 - Leading autoimmune dealmakers and deals
4.1. Introduction
4.2. Most active in autoimmune dealmaking
4.3. List of most active dealmakers in autoimmune
4.4. Top autoimmune deals by value
Chapter 5 - Autoimmune deal contract document directory
5.1. Introduction
5.2. Autoimmune partnering deals where contract document available
Chapter 6 - Autoimmune dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by autoimmune therapeutic target
Deal Directory
- Deal Directory - Autoimmune deals by company A-Z 2016 to 2025
- Deal Directory - Autoimmune deals by technology type 2016 to 2025
A Selection of Companies Featured Include:
- AB Biosciences
- Abbott Laboratories
- Abbvie
- Acucela
- Aculys Pharma
- AdAlta
- Adhera Therapeutics
- Adimune
- Adiso Therapeutics
- Aditum Bio
- Aduro BioTech
- Adynxx
- Agility Life Sciences
- AimedBio
- Akaal Pharma
- Akebia Therapeutics
- Akouos
- Akston Biosciences
- Alex Therapeutics
- Alfasigma
- Alimentiv
- Alimera Sciences
- Alkermes
- Almirall
- AltaVoice
- Alvotech
- Amarna Therapeutics
- Ambiopharm
- Ambry Genetics
- Amegabiotech
- Amgen
- Amytrx Therapeutics
- AnaptysBio
- AnGes MG
- Anokion
- Anthem Bluecross
- AntibioTx
- Antidote
- Aptar Pharma
- Arbor Biotechnologies
- Arch Biopartners
- Arctic Vision
- Arcutis Biotherapeutics
- Arena Pharmaceuticals
- Aristea Therapeutics
- Ark Biosciences
- Aslan Pharma
- Aspect Biosystems
- Astellas Pharma
- Asthma UK
- AstraZeneca
- Astria Therapeutics
- Autolus
- Avacta
- Avalere Health
- Avicanna
- Axela
- Axoltis Pharma
- Axsome Therapeutics
- Azenta Life Sciences
- Azitra
- Bachem
- Back-A-Line
- Basilea Pharmaceutica
- Bausch & Lomb
- Bayer
- BCD Bioscience
- BenevolentAI
- Bennu Pharmaceuticals
- BGI
- Bigfoot Biomedical
- BinnoPharm
- Bio-Gate
- Bio-Path
- Bio-Rad Laboratories
- Bio-Techne
- BioClinica
- Biocon
- Biofourmis
- Biogen
- Bioqube Ventures
- Boehringer Ingelheim
- Boragen
- Boston Pharmaceuticals
- Brain Canada
- Brainomix
- Brickell Biotech
- Bristol-Myers Squibb
- C4X Discovery
- Cabaletta Bio
- Caladrius Biosciences
- Calliditas Therapeutics
- Candid Therapeutics
- Cantargia
- Cara Therapeutics
- CASI Pharmaceuticals
- Celltrion
- Celmatix
- Celsius Therapeutics
- Centessa Pharmaceuticals
- Centurion
- Century Therapeutics
- Charles River Laboratories
- CheckPoint Immunology
- Chugai Pharmaceutical
- Cipla
- Circassia
- Clearside Biomedical
- Clene Nanomedicine
- Cleveland Clinic
- ClinConnect
- Coeptis Therapeutics
- Collplant
- Conduit Pharmaceuticals
- Corrona
- Cosmofix
- Coya Therapeutics
- Cryostem
- CrystalGenomics
- CSL Behring
- Cugene
- Curant Health
- Cynata Therapeutics
- Cyrus Biotechnology
- Cytocom
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Danuo Science Group
- Debiopharm
- Diurnal
- Diversigen
- DNAnexus
- Dr. Falk Pharma
- Dr. Reddy's Laboratories
- Dragonfly Therapeutics
- DreaMed Diabetes
- DyDo Pharma
- Editas Medicine
- EffRx Pharmaceuticals
- Eisai
- Eli Lilly
- ElsaLys Biotech
- Encore Dermatology
- Endo International
- Engitix
- Enosi Therapeutics
- Ensho Therapeutics
- Entera Health
- Enteris Biopharma
- Enzene Biosciences
- EOFlow
- Epicore Biosystems
- EpimAb Biotherapeutics
- epitoMAP
- Epivax
- Equillium
- Eterna Therapeutics
- Ethypharm
- EVA Pharma
- Evidation Health
- Evofem Biosciences
- Evolve BioSystems
- Evommune
- EVOQ Therapeutics
- Evotec
- Ewopharma
- Exagen Diagnostics
- Excelra
- Exscientia
- Fibrogen
- Fluidigm
- Fosun Pharmaceutical
- Frequency Therapeutics
- FSD Pharma
- Fujifilm
- Fuji Pharma
- FutureGen Biopharm
- G42 Healthcare
- Galderma
- GC Biopharma
- GenEdit
- Genentech
- Genetic Analysis
- Genmab
- Genomics
- Genprex
- GenScript ProBio
- Genten Therapeutics
- GentiBio
- Genzyme
- Georgiamune
- Giiant Pharma
- Gilead Sciences
- Glenmark Pharmaceuticals
- Graviton Bioscience
- GRI Bio
- GSK
- Gusto Global
- Gynica
- Halozyme Therapeutics
- Hansa Biopharma
- Haplogen
- Hesperos
- HIBio
- Hoffmann La Roche
- Honeywell
- Horizon Therapeutics
- Humanigen
- IMIDomics
- Immetas Therapeutics
- ImmPACT Bio
- Immugenyx
- ImmunoAdoptive Cell Therapy
- ImmunogenX
- Inception Sciences
- Incyte
- InDex Pharmaceuticals
- Inexia
- Innate Pharma
- Inserm Transfert
- InSilicoTrials
- Insmed Inc
- Integral Molecular
- Intract Pharma
- Intrexon
- Inventiva
- Ionis Pharmaceuticals
- IQVIA
- ISD Immunotech
- Iterative Scopes
- iTolerance
- Izana Bioscience
- Jackson Laboratory
- Janssen Biotech
- Jazz Pharmaceuticals
- Jiangsu Hansoh Pharmaceutical
- Johnson & Johnson
- Jolt Health
- JSR
- Jubilant Radiopharma
- Jubilant Therapeutics
- Jupiter Wellness
- JW Pharmaceutical
- Kadimastem
- Kadmon Pharmaceuticals
- Kaleido Biosciences
- Kamada
- KBI BioPharma
- Kezar Life Sciences
- Kindeva Drug Delivery
- Kiniksa Pharmaceuticals
- Kissei Pharmaceutical
- Kite Pharma
- Klue
- Komodo Health
- Koneksa Health
- Koye Pharmaceuticals
- Kubota Vision
- Landos Biopharma
- Lassen Therapeutics
- LEO Pharma
- Lexicon Pharmaceuticals
- LianBio
- Lipidor
- Lonza
- Lyfebulb
- LyGenesis
- Mabwell Bioscience
- mAbXience
- Mapi Pharma
- Marengo Therapeutics
- Maruho
- Max Biopharma
- Maxcyte
- Medac
- Medgenics
- Medimetriks
- Medison Pharma
- MedRhythms
- Medsenic
- Meiji Seika
- Merck and Co
- Metaba
- Microdrop
- Mimetas
- MiNA Therapeutics
- MiTest Health
- Moderna
- MorphoSys
- Mundipharma
- Mylan Laboratories
- Myovant Sciences
- Myriad Genetics
- Navidea Biopharmaceuticals
- Nektar Therapeutics
- Neogap Therapeutics
- Neoteryx
- Neovacs
- Neovii Pharmaceuticals
- Neurodon
- NeuroGenesis
- Nexel
- Nexilico
- Nippon Shinyaku
- Nitto Denko
- Nkarta Therapeutics
- NLS Pharmaceutics
- Nona Biosciences
- Nordic Pharma Group
- Novartis
- Novo Nordisk
- Nuance Pharma
- Nuevolution
- Numab
- Numares
- NuMedii
- Nutra Pharma
- Nxera Pharma
- Ocumension Therapeutics
- OliX Pharmaceuticals
- OMNY Health
- Orion
- Ossium Health
- Otsuka
- Paladin Labs
- Palisade Bio
- Palleon Pharmaceuticals
- Panaxia
- Pancryos
- Pandion Therapeutics
- Paragon Bioservices
- Parexel Biotech
- Parvus Therapeutics
- Patara Pharma
- PathoQuest
- Pearsanta
- Pediatrix Therapeutics
- Pelle Ventures
- Pfizer
- Pheno Therapeutics
- Philips
- PicnicHealth
- PlantEXT
- Pluristyx
- Pragma Bio
- Precision BioSciences
- PredictImmune
- Priovant Therapeutics
- Progenity
- Promius Pharma
- Propeller Health
- Protagen
- Protxx
- Purdue Pharma
- Quadri Pharmaceuticals
- Recipharm
- RedHill Biopharma
- Redx Pharma
- Regen BioPharma
- Regentys
- Regranion
- Relife
- Remedium Bio
- Renovion
- ReproCell
- RespirAI Medical
- Revive Therapeutics
- Revon Systems
- ReWalk Robotics
- Rheos Medicines
- Rigel Pharmaceuticals
- Roche
- Roivant Sciences
- RS BioTherapeutics
- Sandoz
- Sanguine
- Sanofi
- Sano Genetics
- Savana
- Scailyte
- Schrodinger
- Scienion
- Scipher Medicine
- Second Genome
- Selecta Biosciences
- Selexis
- Semma Therapeutics
- Sengenics
- Seres Therapeutics
- Sernova
- Serosep
- Shaperon
- Shire Laboratories
- Siemens Healthineers
- Sigilon Therapeutics
- Signum Biosciences
- Sirion Biotech
- Sitryx
- Skyhawk Therapeutics
- SomaLogic
- Sonde Health
- Sonoma BioTherapeutics
- Sorrento Therapeutics
- Statera Biopharma
- Surrozen
- SynAct Pharma
- Synaptogenix
- Syndax Pharmaceuticals
- Syneron Bio
- Synlogic
- Synthekine
- Synthonics
- Taiho
- Takara Bio
- Takeda Pharmaceutical
- Teva Pharmaceutical Industries
- TG Therapeutics
- Tharimmune
- Theradiag
- Theramex
- TiGenix
- Tiziana Life Sciences
- TONIX Pharmaceuticals
- Trethera
- True Diagnostics
- True North Therapeutics
- Truveta
- TxCell
- UCB
- UGA Biopharma
- Upsher-Smith
- Vaccinex
- Valo Health
- Variant Bio
- Vcell Healthcare
- Vectura
- Veracyte
- Verily
- Verona Pharma
- Versant Ventures
- Vicore Pharma
- Vital Therapies
- Vium
- Vivtex
- Voronoi
- Wanchunbulin
- WellDyne
- WuXi Biologics
- Xbrane Biopharma
- Xencor
- Xylyx Bio
- Zedira
- Zymeworks
- ZyVersa Therapeutics
For more information about this report visit https://www.researchandmarkets.com/r/gf64wz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
